Invasive Fungal Infections after Liver Transplantation

Area of Science:

• Medical Mycology
• Transplantation Medicine
• Infectious Diseases

Background:

• Invasive fungal infections (IFIs) pose a serious threat to organ transplant recipients.
• Common IFIs include candidiasis, aspergillosis, and cryptococcosis, with variations based on transplant type (e.g., aspergillosis in lung transplants).
• Liver transplant recipients are particularly susceptible to candidiasis and aspergillosis.

Purpose of the Study:

• To review the epidemiology of IFIs in organ transplant patients.
• To identify key risk factors associated with IFIs post-transplantation.
• To outline current prophylaxis and treatment strategies for IFIs, focusing on liver transplant recipients.

Main Methods:

• Literature review of epidemiological data on IFIs in organ transplantation.
• Analysis of identified risk factors contributing to IFIs.
• Summary of established prophylaxis and therapeutic guidelines for IFIs.

Main Results:

• Candidiasis is the most prevalent IFI overall, except in lung transplant recipients where aspergillosis predominates.
• Liver transplant recipients represent a high-risk group for invasive candidiasis and aspergillosis.
• Timely prophylaxis and treatment are critical for favorable outcomes in transplant patients.

Conclusions:

• Understanding IFI epidemiology and risk factors is crucial for managing transplant recipients.
• Targeted prophylaxis, especially in high-risk groups like liver transplant patients, is recommended.
• Effective and prompt therapeutic interventions are essential for improving patient outcomes after organ transplantation.